CP-358,774 small molecule inhibitor of the epidermal growth factor receptor (EGFr) tyrosine kinase:began phase II

OSI Pharmaceuticals Inc. (OSIP), Uniondale, N.Y. Product: CP-358,774 small molecule inhibitor of the epidermal growth factor receptor (EGFr) tyrosine kinase Indication: Treat cancer Status: Followi...